News About: Pharm. Industry
Pharmaceutical firms go all-out for cash
The government’s merciless drug price cuts have promoted pharmaceutical companies to seek more cash to meet the uncertain future.
"Companies are vying to secure cash as the growing liquidity preference has become t...
Falling drug prices increase people’s medication burden
Retail drug prices are expected to fall about 17 percent on average beginning next year following a set of government-led reforms.
However, pharmaceutical firms have denounced government-led price reduction measure...
Dong-A to market GSK’s Polident
Dong-A Pharmaceutical is expected to re-establish a marketing and distribution partnership with GloxoSmithKline Healthcare.
Under the deal, Dong-A will sell Polident, denture cleanser and Sensodyne, toothpaste bran...
Drug makers hold negative view on drug re-categorization
Pharmaceutical companies expressed a negative view toward the idea of re-categorizing medicines as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.
The reac...
Pharmaceutical companies seeking tie-ups over development of anti-obesity drugs
Now that the prevalence of obesity has been increasing at an alarming rate over the past few years, not only in the industrialized nations, but also in the developing ones, the focus of government agencies and pharmac...
JW Pharmaceutical, Kazakh firm sign MOU for amino acid infusions plant
JW Pharmaceutical Corp. Friday signed a memorandum of understanding (MOU) with Kazakhstan's largest pharmaceutical firm JSC Chempharm for a feasibility study on building an amino acid solutions plant.
Together with...
Ildong forges strategic tie-up with Sandoz Korea
Ildong Pharmaceutical Co. says it has established a marketing and distribution partnership with Sandoz Korea.
Under the deal, Ildong will be in charge of selling Sandoz drugs using its extensive domestic distributi...
NHIC urged to clim illegal selling of generic drugs with bioequivalence data fabrication
For more than three years since 2008, the National Health Insurance Corp. has staged an uphill battle with 93 pharmaceutical firms that submitted falsified bioequivalence data on 231 medicines.
In each lawsuit, the...
Green Cross holds symposium for new botanical drug for osteoporosis
Green Cross Corp. said Wednesday that it held a launching symposium for its new botanical drug for osteoporosis treatment, Sinbaro capsule.
About 200 doctors from various departments of orthopedic, rheumatic intern...
Levitra ODT gaining popularity
A growing number of customers here are turning their eyes to Bayer Healthcare’s new dissolvable erectile dysfunction tablet called Levitra ODT (Orodispersible).
With a catchphrase titled ‘Good-Bye Water,’ Levitra O...
